Anderson_2015_Antivir.Ther_20_397

Reference

Title : Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects - Anderson_2015_Antivir.Ther_20_397
Author(s) : Anderson MS , Gilmartin J , Cilissen C , De Lepeleire I , Van Bortel L , Dockendorf MF , Tetteh E , Ancona JK , Liu R , Guo Y , Wagner JA , Butterton JR
Ref : Antivir Ther , 20 :397 , 2015
Abstract : Anderson_2015_Antivir.Ther_20_397
ESTHER : Anderson_2015_Antivir.Ther_20_397
PubMedSearch : Anderson_2015_Antivir.Ther_20_397
PubMedID: 25470746

Related information

Citations formats

Anderson MS, Gilmartin J, Cilissen C, De Lepeleire I, Van Bortel L, Dockendorf MF, Tetteh E, Ancona JK, Liu R, Guo Y, Wagner JA, Butterton JR (2015)
Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects
Antivir Ther 20 :397

Anderson MS, Gilmartin J, Cilissen C, De Lepeleire I, Van Bortel L, Dockendorf MF, Tetteh E, Ancona JK, Liu R, Guo Y, Wagner JA, Butterton JR (2015)
Antivir Ther 20 :397